68
Views
0
CrossRef citations to date
0
Altmetric
Perspectives

Vasoactive neuropeptides in clinical ophthalmology: An association with autoimmune retinopathy?

, &
Pages 259-261 | Published online: 17 Mar 2009

References

  • TervoTTervoKErankoLOcular neuropeptidesMed Biol198260253606178909
  • NillsonSFDe NeefPRobberechtPChristopheJCharacterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclaseExp Eye Res19945844594677925682
  • OnaliPOlianasMCPACAP is a potent and highly effective stimulator of adenylyl cyclase activity in the retinas of different mammalian speciesBrain Res199464111321348019839
  • MartinBLopez de MaturanaRBrennemanRWalentTMattsonMPMaudsleySClass II G protein-coupled receptors and their ligands in neuronal function and protectionNeuromolecular Med200571–233616052036
  • KawamuraHSugiyamaTWuDMATP: a vasoactive signal in the pericyte-containing microvasculature of the rat retinaJ Physiol2003551 (Pt 3)78779912876212
  • SugiyamaTKawamuraHYamanishiSKobayashiMKatsumuraKPuroDGRegulation of P2X7-induced pore formation and cell death in pericyte-containing retinal microvesselsAm J Physiol Cell Physiol20052883C568C57615496477
  • ZhangXZhangMLatiesAMMitchellCHStimulation of P2X7 receptors elevates Ca2+ and kills retinal ganglion cellsInvest Opth Vis Sci200546621832191
  • FahrenkrugJPACAP – a multifacetted neuropeptideChronobiol Int2006231–2536116687279
  • TrogerJKieselbachGTeuchnerBPeptidergic nerves in the eye, their source and potential pathophysiological relevanceBrain Res Rev2007531396216872680
  • RáczBGallyasFJrKissPEffects of pituitary adenylate cyclase activating polypeptide (PACAP) on the PKA-Bad-14-3-3 signaling pathway in glutamate-induced retinal injury in neonatal ratsNeurotox Res20071229510417967733
  • SekiTNakataniMTakiCNeuroprotective effect of PACAP against kainic acid-induced neurotoxicity in rat retinaAnn N Y Acad Sci2006107053153416888220
  • HannibalJMollerMOttersenOPFahrenkrugJPACAP and glutamate are co-stored in the retinohypothalamic tractJ Comp Neurol2000418214715510701440
  • ShogeKMishimaHKSaitohTAttenuation by PACAP of glutamate-induced neurotoxicity in cultured retinal neuronsBrain Res19998391667310482800
  • MarkhotinaNLiuGJMartinDKContractility of retinal pericytes grown on silicone elastomer substrates is through a protein kinase A-mediated intracellular pathway in response to vasoactive peptidesIET Nanobiotechnol200713445117506596
  • AtlaszTBabaiNKissPPituitary adenylate cyclase activating polypeptide is protective in bilateral carotid occlusion-induced retinal lesion in ratsGen Comp Endocrinol20071531–310811417289046
  • CasiniGNeuropeptides and retinal developmentArch Ital Biol20051433–419119816097495
  • StainesDR2006. Does autoimmunity of endogenous vasoactive neuropeptides cause retinopathy in humans?Med Hypotheses200870113714017560049
  • BalashovaLMSaskonovaEOZaitsevaNS[Role of immunological factors in peripheral vitreo-chorioretinal dystrophies and macular ruptures of the retina.]Vestn Oftalmol199511111618[in Russian].7771035
  • AdamusGAutoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathyAutoimmun Rev200322636812848960
  • HeckenlivelyJRFawziAAOversierJJordanBLAptsiauriNAutoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degenerationArch Ophthalmol2000118111525153311074809
  • HooksJJPercopoCWangYDetrickBRetina and retinal pigment epithelial cell autoantibodies are produced during murine coronavirus retinopathyJ Immunol19931516338133898397257
  • VinoresSAWangYVinoresMABlood–retinal barrier breakdown in experimental coronavirus retinopathy: association with viral antigen, inflammation, and VEGF in sensitive and resistant strainsJ Neuroimmunol2002119217518211585619
  • YoshikawaMSuzumuraAItoATamaruTTakayanagiTEffect of phosphodiesterase inhibitors on nitric oxide production by glial cellsTohoku J Exp Med2002196316717712002273
  • SunHACampochiaroPAStimulation of cyclic adenosine monophosphate accumulation causes breakdown of the blood–retinal barrierInvest Ophthalmol Vis Sci1991327200620101647374
  • MitchellCHLuWHuHZhangXReigadaDZhangMThe P2X(7) receptor in retinal ganglion cells: A neuronal model of pressure-induced damage and protection by a shifting purinergic balancePurinergic Signal20084431332118923921
  • SugiyamaTKobayashiMKawamuraHLiQPuroDGEnhancement of P2X (7)-induced pore formation and apoptosis: an early effect of diabetes on the retinal microvasculatureInvest Ophthal Vis Sci20044531026103214985326
  • NewmanEAA dialogue between glia and neurons in the retina: modulation of neuronal excitabilityNeuron Glia Biol20041324525218458754
  • IandievIUckermannOPannickeTGlial cell reactivity in a porcine model of retinal detachmentInvest Ophthalmol Vis Sci20064752161217116639028
  • AbbracchioMPCerutiSRoles of P2 receptors in glial cells: focus on astrocytesPurinergic Signal20062459560418404462
  • PedataFMelaniAPuglieseAMCoppiECiprianiSTrainiCThe role of ATP and adenosine in the brain under normoxic and ischemic conditionsPurinergic Signal20073429931018404443
  • FrankeHSchepperCIllesPKrügelUInvolvement of P2X and P2Y receptors in microglial activation in vivoPurinergic Signal20073443544518404456
  • SperlághBIllesPPurinergic modulation of microglial cell activationPurinergic Signal200731–211712718404425
  • PuthusseryTFletcherEExtracellular ATP induces retinal photoreceptor apoptosis through activation of purinoceptors in rodentsJ Comp Neurol2009513443044019180669
  • BorbaJCHenzeIPSilveiraMSPituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina developmentBrain Res Dev Brain Res20051562193201
  • MiwaTMoriANakaharaTIshiiKIntravenously administered phosphodiesterase 4 inhibitors dilate retinal blood vessels in ratsEur J Pharmacol2009602111211619027003
  • FraunfelderFWFraunfelderFTCentral serous chorioretinopathy associated with sildenafilRetina200828460660918398363
  • CameloSLajavardiLBochotAProtective effect of intravitreal injection of vasoactive intestinal peptide (VIP)-loaded liposomes on experimental autoimmune uveoretinitisJ Ocul Pharmacol Ther200925192219232006